Andrés F. Correa-Sánchez is an experienced professional in the field of biochemistry and chemistry, currently serving as the Head of Oligonucleotide Development and Lead Chemist in Oligonucleotide Synthesis at NATA - Nucleic Acid Therapy Accelerator since July 2021. Prior to this role, Andrés contributed as a Research Assistant and worked as a Scientific Researcher at Universidad Nacional de Colombia from March 2020 to January 2021. Andrés holds a Master's degree in Biochemistry and a Bachelor of Science in Chemistry, both obtained from Universidad Nacional de Colombia between 2011 and 2020.